to the main stream media (MSM). Stories of note today:
All the increased volatility is helping the CME Group (CME). Volume is up 38% compared to the first quarter of 2017.
Shire is setting itself up for sale to Takeda Pharmaceuticals with sale of its cancer drugs to Servier.